The lung parenchyma and adjacent tissues are one of the most common sites of metastatic disease. Traditionally, the approach to treatment of a patient with lung metastases has been with systemic therapy, with radiotherapy being reserved for palliative management of symptomatic disease. The concept of oligo metastatic disease has paved the way for more radical treatment options, administered either alone or as local consolidative therapy in addition to systemic treatment. The modern-day management of lung metastases is guided by a number of factors, including the number of lung metastases, extra-thoracic disease status, overall performance status, and life expectancy, which all help determine the goals of care. Stereotactic body radiotherapy (SBRT) has emerged as a safe and effective method in locally controlling lung metastases, in the oligo metastatic or oligo-recurrent setting. This article outlines the role of radiotherapy in multimodality management of lung metastases.

肺实质和邻近组织是转移性疾病最常见的部位之一。传统上，肺转移患者的治疗方法是全身治疗，放疗仅用于症状性疾病的姑息治疗。寡核苷酸转移性疾病的概念为更彻底的治疗选择铺平了道路，除了全身治疗外，可以单独给药或作为局部巩固治疗。现代肺转移瘤的管理受许多因素的指导，包括肺转移瘤的数量、胸腔外疾病状况、整体体能状况和预期寿命，这些都有助于确定治疗目标。立体定向放疗 (SBRT) 已成为一种安全有效的局部控制肺转移的方法，在寡核苷酸转移或寡核苷酸复发的情况下。本文概述了放射治疗在肺转移的多模式管理中的作用。